This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

VVUS : NASDAQ : Health Care
$4.82 | %
Today's Range: 4.76 - 4.91
Avg. Daily Volume: 2,389,400
07/25/14 - 3:59 PM ET

PEER GROUP: Pharmaceuticals

Ticker Company Name Recent
Net Sales
Net Income
VVUS VIVUS INC 4.60 475.24 n/m 113.66 1755.99
SGNT SAGENT PHARMACEUTICALS INC 25.96 827.22 31.28 255.41 24.25
DEPO DEPOMED INC 11.52 668.06 10.11 184.58 84.28
BDSI BIODELIVERY SCIENCES INTL 12.49 605.14 n/m 30.42 -23.26
TXMD THERAPEUTICSMD INC 4.11 597.76 n/m 10.07 117.35
FLML FLAMEL TECHNOLOGIES SA -ADR 13.49 516.24 n/m 26.48 10.87
OMER OMEROS CORP 13.64 462.56 n/m 0.61 -89.24
SUPN SUPERNUS PHARMACEUTICALS INC 9.28 390.19 n/m 20.95 1376.60
ACRX ACELRX PHARMACEUTICALS INC 8.99 389.89 n/m 28.66 853.64
AMPE AMPIO PHARMACEUTICALS INC 6.59 342.13 n/m 0.05 0.00
PTX PERNIX THERAPEUTICS HOLDINGS 7.91 298.78 n/m 81.85 18.77
The peer group comparison is based on Major Pharmaceuticals companies of comparable size.

Price Earnings Comparison

VVUS Ind Avg S&P 500
n/m 27.20 19.42

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs